+

ES2110993T3 - Anticuerpos monoclonales especificos para la toxina b de clostridium difficile. - Google Patents

Anticuerpos monoclonales especificos para la toxina b de clostridium difficile.

Info

Publication number
ES2110993T3
ES2110993T3 ES91909906T ES91909906T ES2110993T3 ES 2110993 T3 ES2110993 T3 ES 2110993T3 ES 91909906 T ES91909906 T ES 91909906T ES 91909906 T ES91909906 T ES 91909906T ES 2110993 T3 ES2110993 T3 ES 2110993T3
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
clostridium difficile
antibodies specific
difficile toxin
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91909906T
Other languages
English (en)
Inventor
Richard T Coughlin
Dante J Marciani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meridian Bioscience Inc
Original Assignee
Meridian Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meridian Diagnostics Inc filed Critical Meridian Diagnostics Inc
Application granted granted Critical
Publication of ES2110993T3 publication Critical patent/ES2110993T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE PRESENTAN ANTICUERPOS MONOCLONALES ESPECIFICOS DE LA TOXINA B DEL CLOSTRIDIUM DIFFICILE. ADEMAS SE PRESENTAN LOS METODOS PARA HACER Y UTILIZAR LOS ANTICUERPOS, EN PARTICULAR EL USO DE LOS ANTICUERPOS PARA DETECTAR EL C. DIFFICILE.
ES91909906T 1990-05-11 1991-05-06 Anticuerpos monoclonales especificos para la toxina b de clostridium difficile. Expired - Lifetime ES2110993T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/522,881 US5231003A (en) 1990-05-11 1990-05-11 Monoclonal antibodies specific for toxin b of clostridium difficile

Publications (1)

Publication Number Publication Date
ES2110993T3 true ES2110993T3 (es) 1998-03-01

Family

ID=24082747

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91909906T Expired - Lifetime ES2110993T3 (es) 1990-05-11 1991-05-06 Anticuerpos monoclonales especificos para la toxina b de clostridium difficile.

Country Status (11)

Country Link
US (1) US5231003A (es)
EP (1) EP0482176B1 (es)
JP (1) JPH05500011A (es)
AT (1) ATE160575T1 (es)
AU (1) AU655586B2 (es)
CA (1) CA2063709A1 (es)
DE (1) DE69128273T2 (es)
DK (1) DK0482176T3 (es)
ES (1) ES2110993T3 (es)
IE (1) IE911617A1 (es)
WO (1) WO1991018293A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610023A (en) * 1995-03-31 1997-03-11 Lee Laboratories, Inc. Method of purification of clostridium difficile toxin A and production of mono-specific antibodies
US7179611B2 (en) * 1997-02-10 2007-02-20 Bd Lee Laboratories Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A
US5965375A (en) * 1997-04-04 1999-10-12 Biosite Diagnostics Diagnostic tests and kits for Clostridium difficile
DE19739685A1 (de) * 1997-09-10 1999-03-11 Eichel Streiber Christoph Von Monoklonale Antikörper zur Therapie und Prophylaxe von Erkrankungen durch Clostridium difficile
US6290946B1 (en) * 1999-05-13 2001-09-18 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders and antibacterial agents
US6270755B1 (en) 1999-05-13 2001-08-07 Geltex Pharmaceuticals, Inc. Anionic polymers as toxin binders
CA2314494A1 (en) 2000-05-02 2001-11-02 Geltex Pharmaceuticals, Inc. Anionic polymers as species specific antibacterial agents
MXPA05000687A (es) * 2002-07-22 2005-04-08 Genzyme Corp Poli (estirenosulfonato potasico y sodico), su fabricacion y sus usos.
EP1766093B1 (en) 2004-02-06 2011-06-15 University of Massachusetts Antibodies against clostridium difficile toxins and uses thereof
EP1802349A1 (en) * 2004-10-13 2007-07-04 Ilypsa, Inc. Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle
US20060078534A1 (en) * 2004-10-13 2006-04-13 Dominique Charmot Toxin binding compositions
US8598321B2 (en) 2007-03-22 2013-12-03 The Regents Of The University Of California Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
BRPI0906060A2 (pt) 2008-02-28 2015-12-01 3M Innovative Properties Co anticorpos isolados, métodos de preparo de um anticorpo anti-clostridium difficile, composição e método para a detecção da presença de um esporo de clostridium difficile em uma amostra
EP2313434A4 (en) 2008-07-31 2013-03-27 Univ California ANTIBODIES FOR NEUTRALIZING BOTULINE NEUROTOXINES
WO2011012098A1 (de) * 2009-07-27 2011-02-03 Tgcbiomics Gmbh Verfahren zum nachweis und zur identifikation eines varianten c. difficile stammes in einer probe
EP2558493B1 (en) 2010-04-15 2019-09-18 Progenics Pharmaceuticals, Inc. Antibodies for the treatment of clostridium difficile-associated infection and disease
WO2012047427A2 (en) 2010-08-31 2012-04-12 The Regents Of The University Of California Antibodies for botulinum neurotoxins
PL2699587T3 (pl) 2011-04-22 2019-12-31 Wyeth Llc Kompozycje związane ze zmutowaną toksyną C. difficile i sposoby ich wytwarzania
WO2013028810A1 (en) 2011-08-22 2013-02-28 Cangene Corporation Clostridium difficile antibodies
US8790880B2 (en) * 2011-09-26 2014-07-29 Techlab, Inc. Cysteine protease Cwp84 (CD2787) as a diagnostic marker for Clostridium difficile
TWI592422B (zh) 2012-03-02 2017-07-21 再生元醫藥公司 抗艱難梭狀芽孢桿菌毒素之人類抗體
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile
CN114853896B (zh) * 2020-11-30 2023-05-09 四川大学华西医院 一种抗糖基转移酶a亚单位的纳米抗体及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879218A (en) * 1982-09-13 1989-11-07 Virginia Tech Intellectual Properties, Inc. Antibody for C.difficile
US4533630A (en) * 1982-09-13 1985-08-06 Wilkins Tracy D Toxins and antibodies of C. difficile
EP0154064A1 (en) * 1984-03-02 1985-09-11 Tracy Dale Wilkins Toxins and antibodies of C. difficile

Also Published As

Publication number Publication date
EP0482176A4 (en) 1992-08-05
IE911617A1 (en) 1991-11-20
WO1991018293A1 (en) 1991-11-28
EP0482176A1 (en) 1992-04-29
CA2063709A1 (en) 1991-11-12
AU7883091A (en) 1991-12-10
DK0482176T3 (da) 1998-05-18
EP0482176B1 (en) 1997-11-26
ATE160575T1 (de) 1997-12-15
DE69128273T2 (de) 1998-06-25
AU655586B2 (en) 1995-01-05
US5231003A (en) 1993-07-27
JPH05500011A (ja) 1993-01-14
DE69128273D1 (de) 1998-01-08

Similar Documents

Publication Publication Date Title
ES2110993T3 (es) Anticuerpos monoclonales especificos para la toxina b de clostridium difficile.
FI954319A0 (fi) Rapamysiinimääritys
ES2113088T3 (es) Metodo de entrega de agentes a celulas diana.
ATE113845T1 (de) Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung.
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
BG32850A3 (bg) Метод за получаване на 6а,10а-цис-хексахидро- -дибензопиранони
ES2049332T3 (es) Procedimiento para la reduccion de la heterogeneidad de los anticuerpos monoclonales.
BG29722A3 (bg) Метод за получаване на 2,5-дисубституирани пиримидин-4-они
NO162797C (no) Monoklonalt antistofff for anvendelse in vitro.
ES2196150T3 (es) Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.
DK407987A (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
GB737693A (en) Improvements relating to jigs and fixtures
DE3585049D1 (de) Monoklonale antikoerper.
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
BG35749A3 (en) Method for preparing 20- dihydro- 20, 23- dideoxytilonolide
BG33436A3 (en) Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion
FI86255B (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
SE7713700L (sv) 2-substituerade-1-(omega-aminoalkoxi)bensener
ATE125306T1 (de) Monoklonale antikörper, die einen unterschied zwischen nativproteinen und proteinen mit einer modifizierten sequenz machen.
ES2068863T3 (es) Deteccion inmunologica de atracina y de derivados de atracina.
ES2063017T3 (es) Anticuerpos monoclonales para antraciclinas.
DK120158B (da) Analogifremgangsmåde til fremstilling af i 11-stillingen substituerede 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-oner.
SE7613946L (sv) Sekundera eteraminacetat och deras anvendning som preparationsmedel for syntetfibrer
JPS5421209A (en) Test system for intra-office trunks
JPS51128542A (en) Connecting method of photo fibre

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 482176

Country of ref document: ES

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载